These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21592885)

  • 1. [Design of a multicenter registry to evaluate rhythm versus rate control in atrial fibrillation: Atrial Fibrillation Mexican Registry (ReMeFA)].
    Iturralde-Torres P; Lara-Vaca S; Cordero-Cabra A; Nava-Townsend S; Mendoza C; Márquez MF; Saucedo-Sánchez N; Martínez-Flores E
    Arch Cardiol Mex; 2011; 81(1):13-7. PubMed ID: 21592885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Mexican Registry of Atrial Fibrillation (ReMeFa)].
    Lara-Vaca S; Cordero-Cabra A; Martínez-Flores E; Iturralde-Torres P
    Gac Med Mex; 2014 Dec; 150 Suppl 1():48-59. PubMed ID: 25643677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation.
    Ad N; Henry L; Hunt S; Stone L
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1146-52. PubMed ID: 20412955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the cardiac rhythm management device population: the RATE Registry design.
    ;
    Am Heart J; 2009 Jun; 157(6):983-7.e1. PubMed ID: 19464407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registry.
    Amerena J; Chen SA; Sriratanasathavorn C; Cho JG; Huang D; Omar R; Tse HF; King A
    Am J Cardiol; 2012 Feb; 109(3):378-82. PubMed ID: 22118827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).
    Opolski G; Kosior DA; Kurzelewski M; Skrzyńska M; Zagórski A; Janion M; Muzolf M; Wlazłowski R; Pankiewicz B; Łoboz-Grudzień K; Breithardt G;
    Kardiol Pol; 2010 May; 68(5):546-54. PubMed ID: 20491018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
    Le Heuzey JY; Breithardt G; Camm J; Crijns H; Dorian P; Kowey PR; Merioua I; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub W
    Am J Cardiol; 2010 Mar; 105(5):687-93. PubMed ID: 20185018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
    De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
    Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association.
    Arbelo E; Brugada J; Hindricks G; Maggioni A; Tavazzi L; Vardas P; Anselme F; Inama G; Jais P; Kalarus Z; Kautzner J; Lewalter T; Mairesse G; Perez-Villacastin J; Riahi S; Taborsky M; Theodorakis G; Trines S;
    Europace; 2012 Aug; 14(8):1094-103. PubMed ID: 22628450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
    J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
    Badheka AO; Marzouka GR; Rathod AD; Patel NJ; Myerburg RJ; Mitrani RD
    Am J Cardiol; 2013 Jun; 111(12):1759-63. PubMed ID: 23540545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).
    Kakkar AK; Mueller I; Bassand JP; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Lip GY; Mantovani LG; Verheugt FW; Jamal W; Misselwitz F; Rushton-Smith S; Turpie AG
    Am Heart J; 2012 Jan; 163(1):13-19.e1. PubMed ID: 22172431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation--maintaining sinus rhythm versus ventricular rate control: the PIAF trial. Pharmacological Intervention in Atrial Fibrillation.
    Hohnloser SH; Kuck KH
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S121-6. PubMed ID: 9727686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
    Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
    Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
    Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early results.
    Mokadam NA; McCarthy PM; Gillinov AM; Ryan WH; Moon MR; Mack MJ; Gaynor SL; Prasad SM; Wickline SA; Bailey MS; Damiano NR; Ishii Y; Schuessler RB; Damiano RJ
    Ann Thorac Surg; 2004 Nov; 78(5):1665-70. PubMed ID: 15511453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.